Friday's Biggest Health-Care Loser: Nu Skin Enterprises, Inc.

Nu Skin Enterprises (NYSE: NUS  ) fell an additional 10% on Friday after Thursday's plummet of 29%, following a report that the Chinese government will investigate the company as a possible pyramid scheme. Nu Skin is heavily reliant on the Chinese market for growth, so such an investigation will affect the stock negatively, even if nothing is found.

In this video, Fool health-care analyst David Williamson looks at Nu Skin and its relationship with the Chinese market. He tells investors just how strong of an impact this investigation could have on the stock, and whether this week's precipitous fall means a buying opportunity, or that it's time to get out.

Looking for more interesting plays in health care?
The best way to play the biotech space is to find companies that shun the status quo and instead discover revolutionary, groundbreaking technologies. In The Motley Fool's brand-new free report "2 Game-Changing Biotechs Revolutionizing the Way We Treat Cancer," find out about a new technology that Big Pharma is endorsing through partnerships, and the two companies that are set to profit from this emerging drug class. Click here to get your copy today.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2800654, ~/Articles/ArticleHandler.aspx, 4/18/2014 7:38:13 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement